F.A. Fitzpatrick

2.8k total citations · 1 hit paper
34 papers, 2.4k citations indexed

About

F.A. Fitzpatrick is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, F.A. Fitzpatrick has authored 34 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Pharmacology and 8 papers in Biochemistry. Recurrent topics in F.A. Fitzpatrick's work include Inflammatory mediators and NSAID effects (14 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). F.A. Fitzpatrick is often cited by papers focused on Inflammatory mediators and NSAID effects (14 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). F.A. Fitzpatrick collaborates with scholars based in United States, Jordan and Canada. F.A. Fitzpatrick's co-authors include Michael A. Wynalda, Robert J. Smith, S Bunting, John E. Bleasdale, Nirja Thakur, Gordon L. Bundy, D.A. Stringfellow, Kelly Doyle, James E. Mullally and Kornelia Edes and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

F.A. Fitzpatrick

34 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

1990 566 citations F.A. Fitzpatrick, Robert J. Smith et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

F.A. Fitzpatrick

PHARM

BIOCH

PHYSI

IMMUN

Chakkodabylu S. Ramesha United States

Gordon L. Bundy United States

Vinay S. Bansal United States

Wayne C. Glasgow United States

Diane Haddock Russell United States

Randy T. McConnell United States

Emer M. Smyth United States

Lisa M. Leesnitzer United States

Sharon Sadowski United States

Shivendra D. Shukla United States

Chakkodabylu S. Ramesha United States

F.A. Fitzpatrick

1.2k ×1.0

534 ×1.0

PHARM

256 ×0.6

BIOCH

340 ×1.2

PHYSI

294 ×1.2

IMMUN

Citations per year, relative to F.A. Fitzpatrick F.A. Fitzpatrick (= 1×) peers Chakkodabylu S. Ramesha

Countries citing papers authored by F.A. Fitzpatrick

Since Specialization

Citations

This map shows the geographic impact of F.A. Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.A. Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.A. Fitzpatrick more than expected).

Fields of papers citing papers by F.A. Fitzpatrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.A. Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.A. Fitzpatrick. The network helps show where F.A. Fitzpatrick may publish in the future.

Co-authorship network of co-authors of F.A. Fitzpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of F.A. Fitzpatrick. A scholar is included among the top collaborators of F.A. Fitzpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.A. Fitzpatrick. F.A. Fitzpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al-Salihi, Mazin A., et al.. (2015). Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of ApcMin/+ mice. Redox Biology. 6. 218–225. 19 indexed citations

Doyle, Kelly & F.A. Fitzpatrick. (2010). Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function. Journal of Biological Chemistry. 285(23). 17417–17424. 128 indexed citations

Slattery, Martha L., Jennifer S. Herrick, Abbie Lundgreen, et al.. (2010). Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR , PTEN , STK11 , RPKAA1 , PRKAG2 , TSC1 , TSC2 , PI3K and Akt1. Carcinogenesis. 31(9). 1604–1611. 77 indexed citations

Covey, Tracy M., Kornelia Edes, & F.A. Fitzpatrick. (2007). Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene. 26(39). 5784–5792. 72 indexed citations

Mullally, James E., et al.. (2005). Reactive Lipid Species from Cyclooxygenase-2 Inactivate Tumor Suppressor LKB1/STK11. Journal of Biological Chemistry. 281(5). 2598–2604. 58 indexed citations

Yu, Margaret K., Philip J. Moos, Pamela B. Cassidy, Mark Wade, & F.A. Fitzpatrick. (2004). Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase. Journal of Biological Chemistry. 279(27). 28028–28035. 29 indexed citations

Moos, Philip J., et al.. (2003). Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase. Journal of Biological Chemistry. 278(2). 745–750. 132 indexed citations

Mullally, James E. & F.A. Fitzpatrick. (2002). Pharmacophore Model for Novel Inhibitors of Ubiquitin Isopeptidases That Induce p53-Independent Cell Death. Molecular Pharmacology. 62(2). 351–358. 86 indexed citations

Malcolm, Kenneth C. & F.A. Fitzpatrick. (1992). Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1244–1249. 18 indexed citations

10.

Bernström, Kerstin, et al.. (1992). Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids.. Journal of Biological Chemistry. 267(6). 3686–3690. 59 indexed citations

11.

Malcolm, Kenneth C. & F.A. Fitzpatrick. (1992). Epoxyeicosatrienoic acids inhibit Ca2+ entry into platelets stimulated by thapsigargin and thrombin.. Journal of Biological Chemistry. 267(28). 19854–19858. 37 indexed citations

12.

Cass, Wayne A., Gaynor A. Larson, F.A. Fitzpatrick, & Nancy R. Zahniser. (1991). Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 990–996. 17 indexed citations

13.

Smith, Robert J., Dennis E. Van Epps, James M. Justen, et al.. (1987). Human neutrophil activation with interleukin-1. Biochemical Pharmacology. 36(22). 3851–3858. 41 indexed citations

14.

Fitzpatrick, F.A., et al.. (1986). Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry.. Journal of Biological Chemistry. 261(32). 15334–15338. 143 indexed citations

15.

Bunting, S, et al.. (1986). Leukotriene B4 and 20-hydroxyleukotriene B4 contract guinea-pig trachea strips in vitro.. Journal of Pharmacology and Experimental Therapeutics. 237(3). 888–892. 9 indexed citations

16.

Fitzpatrick, F.A. & Michael A. Wynalda. (1983). Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.. Journal of Biological Chemistry. 258(19). 11713–11718. 293 indexed citations

17.

Fitzpatrick, F.A. & Dale A. Stringfellow. (1983). Influence of thromboxane synthetase inhibitors on virus replication in human lung fibroblasts in vitro. Biochemical and Biophysical Research Communications. 116(1). 264–271. 3 indexed citations

18.

Wynalda, Michael A., et al.. (1982). A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.. Journal of Pharmacology and Experimental Therapeutics. 220(2). 229–235. 53 indexed citations

19.

Stringfellow, Dale A. & F.A. Fitzpatrick. (1979). Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature. 282(5734). 76–78. 91 indexed citations

20.

Stringfellow, D.A., F.A. Fitzpatrick, F.F. Sun, & James C. McGuire. (1978). Prostacyclin biosynthesis in activated, stimulated and normal mouse peritoneal cell populations. Prostaglandins. 16(6). 901–910. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact